Skip to main content
Equibles

LTGO · Latigo Biotherapeutics, Inc. · Holdings

Track LTGO — free

Use LTGO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LTGO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$15.26 +0.24 (+1.60%) At close · Oct 26
Rebalance outlook locked
Going-concern doubt — cleared Sep 3, 2026

The latest filing states the doubt was alleviated.

“Accordingly, the prior substantial doubt about the Company's ability to continue as a going concern has been alleviated.”
View the 10-Q filed Sep 3, 2026
Market Cap
$954.38M
Shares
66.30M
Volume · Oct 26 165.33K Avg daily vol (56 sessions) 349.92K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Use institutional holdings through the 13F API or MCP → See every holder of LTGO: 13F, 13D and 13G, insiders and funds →
Some SEC filings for this period have not finished importing. Holder totals and changes may be incomplete; these filings remain queued for recovery.

No Holdings Data

No institutional holdings data is available for this listed security yet.

Key facts CIK 2056611 CUSIP 517954103 Visit website Investor relations